The Six Neglected Tropical Diseases
Leprosy is a chronic bacterial disease that attacks skin and nerves of the infected individual. Without treatment leprosy leads to deformities of the face and limbs as well as nerve damage and other complications. Antibiotic treatments can provide a cure for leprosy.
The six neglected tropical diseases are leprosy also known as Hansen's disease, lymphatic filariasis (LF), Onchocerciasis (river blindness), soil transmitted helminths (STH), trachoma and also schistosomiasis.
Leprosy is a chronic bacterial disease that attacks skin and nerves of the infected individual. Without treatment leprosy leads to deformities of the face and limbs as well as nerve damage and other complications. Antibiotic treatments can provide a cure for leprosy. There are two organizations that have a goal of ending this disease from the world. These two organizations are American Leprosy Missions and International Federation of Anti-Leprosy Associations (ILEP). These two organizations provide medical care for those who suffer from leprosy around the world.
Lymphatic filariasis (LF) is a mosquito-borne parasitic disease. The disease causes damage to the lymphatic system. The result of the disease is incapacitation and disfigurement of limbs, breasts, skin and limbs. Individuals with lymphatic filariasis cannot live a normal social or working life because of the disfigurement. Anti-parasitic drugs can break the cycle of infestation. Political awareness, financial and technical support have been mobilized by the Global Alliance to Eliminate Lymphatic filariasis.
|
Tropical Diseases in Brasil
Cholera is still present in 58 countries as of 2001 where 185,000 cases were reported to the World Health Organization (WHO).
Ingesting contaminated water or food can put you at risk for contracting cholera.
Royal Society Of Tropical Medicine
|
Onchocerciasis is also known as river blindness. This is another parasitic disease that is transmitted to individuals by black flies. When individuals bathe, fish or collect water from the rivers where flies breed they can become infected with onchocerciasis. Once infected individuals suffer intense itching, and skin diseases called leopard or lizard skin. They can also develop eye lesions, which result in blindness. A medication: MectizanTM reduces the parasitic transmission and can reduce the symptoms and clinical manifestations of onchocerciasis. The medication relieves the itching and can even clear the eyes, except in advanced cases. 19 countries have banned together to form The African Program for Onchocerciasis Control to help fight the disease and to activate community-directed treatment programs. Another program, The Onchocerciasis Elimination Program for the Americas has a goal to eliminate the morbidity and transmission of onchocerciasis in six endemic (restricted to a locality or region) countries in the Americas.
Soil transmitted helminths (STH), are parasitic disease caused by roundworm, whipworm and hookworm. Contact is made with the worms by coming in contact with contaminated feces or unclean water. The disease causes anemia, vitamin A deficiency, stunted growth, malnutrition and also intestinal obstruction. In some countries as much as 90% of the children suffer from STH. STHs can cause severe health risks including impaired physical and cognitive development in kids. Anti-parasitic drugs can help cure and rid these areas of the disease. Tools, training and technical information is provided to individuals by Partners for Parasite Control (PPC).
Schistosomiasis is also known as Bilharzia. This disease is contracted by blood transmission by way of freshwater snails. The symptoms of the disease are: blood in the urine, anemia, impaired growth, and life-threatening bladder cancer. Kidney malfunction, liver and spleen complications are also common complications of the disease. The drug praziquantel can treat those infected with this disease. The disease can also be controlled by providing adequate disposal methods for feces and urine. The organization, Schistosomiasis Control Initiative (SCI) is helping those who are at high risk in Sub- Saharan Africa.
Tropical Disease Dangers!
09/03/2010
Research At GHESKIO Leads To Update In WHO Guidelines For HIV Treatment
Prompted by clinical research into the early initiation of antiretroviral therapies for HIV performed at the GHESKIO clinic in Port-au-Prince, Haiti, the World Health Organization (WHO) has revised its treatment protocols for HIV patients. Final results from the four-year study, led by Weill Cornell Medical College's infectious and tropical disease experts, were published in the July 15 issue of ...
Research At GHESKIO Leads To Update In WHO Guidelines For HIV Treatment
09/03/2010
Novartis And Collaborators Discover Novel Antimalarial Drug Candidate
New antimalarial drug candidate with novel mechanism of action has the potential to rapidly clear a Plasmodium infection upon administration of a single oral dose, as published in ScienceNovartis announced today that scientists at the Novartis Institute for Tropical Diseases (NITD), in collaboration with researchers from the Genomics Institute of the Novartis Research Foundation (GNF), the Swiss ...
Novartis And Collaborators Discover Novel Antimalarial Drug Candidate
08/30/2010
Tropical Storm Fiona May Get Slightly Stronger
Tropical Storm Fiona could strengthening slightly during the next 24 hours, followed by little change in intensity after that. FIONA: Computer Models | 5-Day Path
Tropical Storm Fiona May Get Slightly Stronger
08/31/2010
How Disease-Causing Parasite Gets Around Human Innate Immunity
Trypanosomes are parasites responsible for many human and animal diseases, primarily in tropical climates. One disease these parasites cause, African sleeping sickness, results from the bite of infected tsetse flies, putting over 60 million Africans at risk in 36 sub-Saharan countries. The recent 1998-2001 sleeping sickness epidemics in South Sudan, Angola, Democratic Republic of Congo and ...
How Disease-Causing Parasite Gets Around Human Innate Immunity
09/03/2010
News From The Journal Of Clinical Investigation: Sept. 1, 2010
INFECTIOUS DISEASE: Modified adenovirus malaria vaccine works a treat in mice Malaria kills more than 1 million individuals each year. Despite intensive research, there is still no malaria vaccine approved for use. A team of researchers, led by Moriya Tsuji, at the Aaron Diamond AIDS Research Center, New York, has now designed a new vaccine that provides protection from malaria in mice. The team ...
News From The Journal Of Clinical Investigation: Sept. 1, 2010
08/31/2010
How Disease-Causing Parasite Gets Around Human Innate Immunity
Trypanosomes are parasites responsible for many human and animal diseases, primarily in tropical climates. One disease these parasites cause, African sleeping sickness, results from the bite of infected tsetse flies, putting over 60 million Africans at risk in 36 sub-Saharan countries. The recent 1998-2001 sleeping sickness epidemics in South Sudan, Angola, Democratic Republic of Congo and ...
How Disease-Causing Parasite Gets Around Human Innate Immunity
09/03/2010
News From The Journal Of Clinical Investigation: Sept. 1, 2010
INFECTIOUS DISEASE: Modified adenovirus malaria vaccine works a treat in mice Malaria kills more than 1 million individuals each year. Despite intensive research, there is still no malaria vaccine approved for use. A team of researchers, led by Moriya Tsuji, at the Aaron Diamond AIDS Research Center, New York, has now designed a new vaccine that provides protection from malaria in mice. The team ...
News From The Journal Of Clinical Investigation: Sept. 1, 2010
09/03/2010
News From The Journal Of Clinical Investigation: Sept. 1, 2010
INFECTIOUS DISEASE: Modified adenovirus malaria vaccine works a treat in mice Malaria kills more than 1 million individuals each year. Despite intensive research, there is still no malaria vaccine approved for use. A team of researchers, led by Moriya Tsuji, at the Aaron Diamond AIDS Research Center, New York, has now designed a new vaccine that provides protection from malaria in mice. The team ...
News From The Journal Of Clinical Investigation: Sept. 1, 2010
09/03/2010
Research At GHESKIO Leads To Update In WHO Guidelines For HIV Treatment
Prompted by clinical research into the early initiation of antiretroviral therapies for HIV performed at the GHESKIO clinic in Port-au-Prince, Haiti, the World Health Organization (WHO) has revised its treatment protocols for HIV patients. Final results from the four-year study, led by Weill Cornell Medical College's infectious and tropical disease experts, were published in the July 15 issue of ...
Research At GHESKIO Leads To Update In WHO Guidelines For HIV Treatment
| 